US 10369232
Allele selective gene editing and uses thereof
granted A61KA61K48/005A61P
Quick answer
US patent 10369232 (Allele selective gene editing and uses thereof) held by ARCTURUS THERAPEUTICS, INC. expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCTURUS THERAPEUTICS, INC.
- Grant date
- Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K48/005, A61P, A61P15/00, A61P17/00